GlassScriptPhysician profile
Daniel Dean Salmon
NPI 1659676906
$7,660.90
in general payments reported to CMS, 2019-2025
35 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $137 · 2022: $808 · 2023: $1,039 · 2024: $4,383 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,607 · Consulting Fee: $2,795 · Travel and Lodging: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,607.25 |
| Consulting Fee | $2,795.00 |
| Travel and Lodging | $313.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Modernatx, INC. | $3,173.71 | 2024 | Moderna Covid-19 Vaccine |
| Novo Nordisk INC | $1,054.55 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $402.83 | 2022-2025 | |
| Lilly USA, LLC | $394.89 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Abbvie INC. | $378.33 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $260.63 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $240.60 | 2021-2025 | Jardiance |
| Glaxosmithkline, LLC. | $238.04 | 2022-2025 | Shingrix, Bexsero, Pediarix |
| Otsuka America Pharmaceutical, INC. | $215.72 | 2022-2023 | Rexulti |
| Phathom Pharmaceuticals, INC. | $149.79 | 2024-2025 | Voquezna |
| Xeris Pharmaceuticals, INC. | $130.00 | 2023-2025 | Gvoke Hypopen |
| Genentech USA, INC. | $129.64 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $119.09 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $66.12 | 2022 | |
| Exact Sciences Corporation | $65.51 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $64.50 | 2021-2025 | Nexletol |
| Biohaven Pharmaceuticals, INC. | $58.36 | 2021 | |
| Sanofi-Aventis U.S. LLC | $55.94 | 2023-2025 | |
| Axsome Therapeutics, INC. | $55.11 | 2022-2025 | Auvelity |
| Merck Sharp & Dohme LLC | $51.52 | 2022-2024 | Belsomra, Capvaxive, Gardasil 9 |
| Dynavax Technologies Corporation | $31.05 | 2022-2024 | Heplisav-B |
| Ultragenyx Pharmaceutical INC. | $30.96 | 2022 | |
| Lundbeck LLC | $30.64 | 2022 | |
| Idorsia Pharmaceuticals US INC | $30.28 | 2022-2023 | Quviviq |
| Amgen INC. | $27.97 | 2025 | Otezla, Repatha, Evenity |
| Novartis Pharmaceuticals Corporation | $27.43 | 2025 | |
| Edwards Lifesciences Corporation | $27.16 | 2025 | |
| Alexion Pharmaceuticals, INC. | $26.65 | 2022 | |
| Alkermes, INC. | $21.24 | 2021 | |
| Janssen Pharmaceuticals, INC | $18.35 | 2023 | Xarelto |
| Amarin Pharma, INC. | $18.03 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $18.01 | 2025 | Eliquis |
| Kowa Pharmaceuticals America, INC. | $17.13 | 2023 | Livalo |
| Seqirus USA INC | $16.92 | 2024 | Flucelvax, Fluad |
| Antares Pharma, INC. | $14.20 | 2025 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Salmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.